Co-Authors
This is a "connection" page, showing publications co-authored by LAURA BERETTA and PENG WEI.
Connection Strength
1.688
-
Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor. Cancer Prev Res (Phila). 2023 01 04; 16(1):17-28.
Score: 0.229
-
Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease. Front Genet. 2022; 13:995488.
Score: 0.226
-
Gut Microbiome Alterations Associated with Diabetes in Mexican Americans in South Texas. mSystems. 2022 06 28; 7(3):e0003322.
Score: 0.218
-
Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease. Hepatology. 2022 04; 75(4):955-967.
Score: 0.213
-
Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila). 2021 10; 14(10):955-962.
Score: 0.206
-
Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics. Cancer Epidemiol Biomarkers Prev. 2021 09; 30(9):1643-1651.
Score: 0.206
-
A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila). 2021 06; 14(6):667-674.
Score: 0.202
-
Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican-American Population of South Texas. Hepatol Commun. 2020 Apr; 4(4):555-568.
Score: 0.188